Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 — Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1…
Can Oral Formulations of Biologics Work?
Although biologics are usually given by injection or intravenous infusion, oral formulations might be possible. In general, oral drugs offer many benefits, from simplified distribution to overall cost reductions for patients, as well as being easier use and often have better patient compliance. Nonetheless, acids and enzymes in the stomach can degrade biologics even before […]
Employers are spending more on GLP-1 drugs, but the ROI is already here
GLP-1 weight loss treatment can be pricey. But employers who cover the treatments could end up saving on employee medical expenses overall. The finding is according to a new analysis of health insurance claims by global professional services firm, Aon, released Wednesday. The report looked at data for more than 50 million commercially insured people […]
Metformin, in a 7-day trial, blocked prednisone-induced insulin resistance by raising GLP-1, blunting insulin secretion, and downregulating lipid metabolism genes. It also showed signs of protecting muscle and bone, suggesting broader metabolic benefits.
submitted by /u/bevatsulfieten [link] [comments]
Weight loss drugs can help employers cut health care costs, study says
Covering the cost of pricey GLP-1 weight loss drugs could pay off for employers by cutting overall medical spending for people taking the medications, but not until year two, according to a massive analysis of health insurance claims by Aon released on Wednesday. Read more…
Humbi AI by Innovaccer and Landmark Science to Present Real-World Evidence on GLP-1 Use for Cardiometabolic and Cardiovascular Risk Reduction in Medicare Populations at ISPOR 2025
MONTREAL–(BUSINESS WIRE)–Innovaccer, the leading healthcare AI company, today announced that its recently acquired actuarial science company – Humbi AI, in collaboration with Landmark Science, Inc., will present a joint research at the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2025 annual conference, scheduled to take place between May 13–16 in Montreal, QC, Canada. […]
Novo Nordisk strikes telehealth deals for obesity drug, following Eli Lilly – statnews.com
Novo Nordisk strikes telehealth deals for obesity drug, following Eli Lilly statnews.com Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23% CNBC Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership Yahoo Finance Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead WSJ Novo Nordisk expands patient access to authentic, FDA-approved […]
What’s driving the rise of GLP-1 utilization in children?
Gen Alpha (children 14 and younger) led the rise of GLP-1 utilization from 2023 to 2024, with an 85% growth rate in that period. But what is behind the sharp increase? 3 factors at play There are several factors behind increased GLP-1 utilization in children. 1. The first is the obesity epidemic. About one-third of […]
Why Ozempic and Wegovy Might Change Your Favorite Food
Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for meats or fried foods, and scientists are beginning to figure out why
GLP-1s can help employers lower medical costs in 2 years, new study finds
As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.